Registration

FABIANI & COMPANY for CODA THERAPEUTICS, INC.

Firm
Client
Income
—
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Defense DEF

Seeking to secure funding for development of gap junction modulator (biologic product) to improve wound healing and patient outcome

LobbyistCovered position, as disclosed
ELIZABETH BARROWS New —
MELISSA DUPREE New —
WENDY SHELTON New —
JEFFREY STUART WIENER New —

Budget/Appropriations BUD

Seeking to secure funding for development of gap junction modulator (biologic product) to improve wound healing and patient outcome

LobbyistCovered position, as disclosed
ELIZABETH BARROWS New —
MELISSA DUPREE New —
WENDY SHELTON New —
JEFFREY STUART WIENER New —

Veterans VET

Seeking to secure funding for development of gap junction modulator (biologic product) to improve wound healing and patient outcome

LobbyistCovered position, as disclosed
ELIZABETH BARROWS New —
MELISSA DUPREE New —
WENDY SHELTON New —
JEFFREY STUART WIENER New —

Medical/Disease Research/Clinical Labs MED

Seeking to secure funding for development of gap junction modulator (biologic product) to improve wound healing and patient outcome

LobbyistCovered position, as disclosed
ELIZABETH BARROWS New —
MELISSA DUPREE New —
WENDY SHELTON New —
JEFFREY STUART WIENER New —

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
GBS BIOVENTURES III TRUST Austria Austria 21.0% —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.